Industry: Pharma & Healthcare
Published Date: 2024-04-07
Pages: 115 Pages
Report ld: 2709104
Request Sample
Customized Report
Metronidazole Market Size(US$)

CAGR 2024-2030
-0.5%
Market Size,2030
USD 109.1
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
The global Metronidazole market is projected to grow from US$ 112.4 million in 2024 to US$ 109.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of -0.5% during the forecast period.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
Report Covers:
This report presents an overview of global market for Metronidazole, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Metronidazole, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Metronidazole, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Metronidazole sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Metronidazole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Metronidazole sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Metronidazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Metronidazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Metronidazole sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Metronidazole Product Introduction
1.2 Market by Type
1.2.1 Global Metronidazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Glyoxal Process
1.2.3 Ethidene Diamine Process
1.2.4 Others
1.3 Market by Application
1.3.1 Global Metronidazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Metronidazole Tablets
1.3.3 Metronidazole Capsule
1.3.4 Metronidazole Injection
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Metronidazole Sales Estimates and Forecasts 2019-2030
2.2 Global Metronidazole Revenue by Region
2.2.1 Global Metronidazole Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Metronidazole Revenue by Region (2019-2024)
2.2.3 Global Metronidazole Revenue by Region (2025-2030)
2.2.4 Global Metronidazole Revenue Market Share by Region (2019-2030)
2.3 Global Metronidazole Sales Estimates and Forecasts 2019-2030
2.4 Global Metronidazole Sales by Region
2.4.1 Global Metronidazole Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Metronidazole Sales by Region (2019-2024)
2.4.3 Global Metronidazole Sales by Region (2025-2030)
2.4.4 Global Metronidazole Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Metronidazole Sales by Manufacturers
3.1.1 Global Metronidazole Sales by Manufacturers (2019-2024)
3.1.2 Global Metronidazole Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Metronidazole in 2023
3.2 Global Metronidazole Revenue by Manufacturers
3.2.1 Global Metronidazole Revenue by Manufacturers (2019-2024)
3.2.2 Global Metronidazole Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Metronidazole Revenue in 2023
3.3 Global Key Players of Metronidazole, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Metronidazole Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Metronidazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Metronidazole, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Metronidazole, Product Offered and Application
3.8 Global Key Manufacturers of Metronidazole, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Metronidazole Sales by Type
4.1.1 Global Metronidazole Historical Sales by Type (2019-2024)
4.1.2 Global Metronidazole Forecasted Sales by Type (2025-2030)
4.1.3 Global Metronidazole Sales Market Share by Type (2019-2030)
4.2 Global Metronidazole Revenue by Type
4.2.1 Global Metronidazole Historical Revenue by Type (2019-2024)
4.2.2 Global Metronidazole Forecasted Revenue by Type (2025-2030)
4.2.3 Global Metronidazole Revenue Market Share by Type (2019-2030)
4.3 Global Metronidazole Price by Type
4.3.1 Global Metronidazole Price by Type (2019-2024)
4.3.2 Global Metronidazole Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Metronidazole Sales by Application
5.1.1 Global Metronidazole Historical Sales by Application (2019-2024)
5.1.2 Global Metronidazole Forecasted Sales by Application (2025-2030)
5.1.3 Global Metronidazole Sales Market Share by Application (2019-2030)
5.2 Global Metronidazole Revenue by Application
5.2.1 Global Metronidazole Historical Revenue by Application (2019-2024)
5.2.2 Global Metronidazole Forecasted Revenue by Application (2025-2030)
5.2.3 Global Metronidazole Revenue Market Share by Application (2019-2030)
5.3 Global Metronidazole Price by Application
5.3.1 Global Metronidazole Price by Application (2019-2024)
5.3.2 Global Metronidazole Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Metronidazole Market Size by Type
6.1.1 US & Canada Metronidazole Sales by Type (2019-2030)
6.1.2 US & Canada Metronidazole Revenue by Type (2019-2030)
6.2 US & Canada Metronidazole Market Size by Application
6.2.1 US & Canada Metronidazole Sales by Application (2019-2030)
6.2.2 US & Canada Metronidazole Revenue by Application (2019-2030)
6.3 US & Canada Metronidazole Market Size by Country
6.3.1 US & Canada Metronidazole Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Metronidazole Sales by Country (2019-2030)
6.3.3 US & Canada Metronidazole Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Metronidazole Market Size by Type
7.1.1 Europe Metronidazole Sales by Type (2019-2030)
7.1.2 Europe Metronidazole Revenue by Type (2019-2030)
7.2 Europe Metronidazole Market Size by Application
7.2.1 Europe Metronidazole Sales by Application (2019-2030)
7.2.2 Europe Metronidazole Revenue by Application (2019-2030)
7.3 Europe Metronidazole Market Size by Country
7.3.1 Europe Metronidazole Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Metronidazole Sales by Country (2019-2030)
7.3.3 Europe Metronidazole Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Metronidazole Market Size
8.1.1 China Metronidazole Sales (2019-2030)
8.1.2 China Metronidazole Revenue (2019-2030)
8.2 China Metronidazole Market Size by Application
8.2.1 China Metronidazole Sales by Application (2019-2030)
8.2.2 China Metronidazole Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Metronidazole Market Size by Type
9.1.1 Asia Metronidazole Sales by Type (2019-2030)
9.1.2 Asia Metronidazole Revenue by Type (2019-2030)
9.2 Asia Metronidazole Market Size by Application
9.2.1 Asia Metronidazole Sales by Application (2019-2030)
9.2.2 Asia Metronidazole Revenue by Application (2019-2030)
9.3 Asia Metronidazole Sales by Region
9.3.1 Asia Metronidazole Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Metronidazole Revenue by Region (2019-2030)
9.3.3 Asia Metronidazole Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Metronidazole Market Size by Type
10.1.1 Middle East, Africa and Latin America Metronidazole Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Metronidazole Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Metronidazole Market Size by Application
10.2.1 Middle East, Africa and Latin America Metronidazole Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Metronidazole Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Metronidazole Sales by Country
10.3.1 Middle East, Africa and Latin America Metronidazole Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Metronidazole Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Metronidazole Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Hongyuan Pharmaceutical
11.1.1 Hongyuan Pharmaceutical Company Information
11.1.2 Hongyuan Pharmaceutical Overview
11.1.3 Hongyuan Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Hongyuan Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hongyuan Pharmaceutical Recent Developments
11.2 Yinhe Aarti Pharmaceutical
11.2.1 Yinhe Aarti Pharmaceutical Company Information
11.2.2 Yinhe Aarti Pharmaceutical Overview
11.2.3 Yinhe Aarti Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Yinhe Aarti Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Yinhe Aarti Pharmaceutical Recent Developments
11.3 Saikang Pharmaceutical
11.3.1 Saikang Pharmaceutical Company Information
11.3.2 Saikang Pharmaceutical Overview
11.3.3 Saikang Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Saikang Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Saikang Pharmaceutical Recent Developments
11.4 Zhongan Pharmaceutical
11.4.1 Zhongan Pharmaceutical Company Information
11.4.2 Zhongan Pharmaceutical Overview
11.4.3 Zhongan Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Zhongan Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zhongan Pharmaceutical Recent Developments
11.5 Wuyao Pharmaceutical
11.5.1 Wuyao Pharmaceutical Company Information
11.5.2 Wuyao Pharmaceutical Overview
11.5.3 Wuyao Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Wuyao Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wuyao Pharmaceutical Recent Developments
11.6 Yichang Changjiang Pharmaceutical
11.6.1 Yichang Changjiang Pharmaceutical Company Information
11.6.2 Yichang Changjiang Pharmaceutical Overview
11.6.3 Yichang Changjiang Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Yichang Changjiang Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Yichang Changjiang Pharmaceutical Recent Developments
11.7 Tongji Pharmaceutical
11.7.1 Tongji Pharmaceutical Company Information
11.7.2 Tongji Pharmaceutical Overview
11.7.3 Tongji Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Tongji Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tongji Pharmaceutical Recent Developments
11.8 Hongda Pharmaceutical
11.8.1 Hongda Pharmaceutical Company Information
11.8.2 Hongda Pharmaceutical Overview
11.8.3 Hongda Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Hongda Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hongda Pharmaceutical Recent Developments
11.9 Topsun Pharmaceutical
11.9.1 Topsun Pharmaceutical Company Information
11.9.2 Topsun Pharmaceutical Overview
11.9.3 Topsun Pharmaceutical Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Topsun Pharmaceutical Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Topsun Pharmaceutical Recent Developments
11.10 Unichem Laboratories
11.10.1 Unichem Laboratories Company Information
11.10.2 Unichem Laboratories Overview
11.10.3 Unichem Laboratories Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Unichem Laboratories Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Unichem Laboratories Recent Developments
11.11 CordenPharma Farchemia
11.11.1 CordenPharma Farchemia Company Information
11.11.2 CordenPharma Farchemia Overview
11.11.3 CordenPharma Farchemia Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 CordenPharma Farchemia Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CordenPharma Farchemia Recent Developments
11.12 API Polpharma
11.12.1 API Polpharma Company Information
11.12.2 API Polpharma Overview
11.12.3 API Polpharma Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 API Polpharma Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 API Polpharma Recent Developments
11.13 Manav Drugs
11.13.1 Manav Drugs Company Information
11.13.2 Manav Drugs Overview
11.13.3 Manav Drugs Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Manav Drugs Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Manav Drugs Recent Developments
11.14 Aarey Drugs & Pharmaceuticals
11.14.1 Aarey Drugs & Pharmaceuticals Company Information
11.14.2 Aarey Drugs & Pharmaceuticals Overview
11.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Aarey Drugs & Pharmaceuticals Recent Developments
11.15 Aarti Drugs
11.15.1 Aarti Drugs Company Information
11.15.2 Aarti Drugs Overview
11.15.3 Aarti Drugs Metronidazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Aarti Drugs Metronidazole Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Aarti Drugs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Metronidazole Industry Chain Analysis
12.2 Metronidazole Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Metronidazole Production Mode & Process
12.4 Metronidazole Sales and Marketing
12.4.1 Metronidazole Sales Channels
12.4.2 Metronidazole Distributors
12.5 Metronidazole Customers
13 Market Dynamics
13.1 Metronidazole Industry Trends
13.2 Metronidazole Market Drivers
13.3 Metronidazole Market Challenges
13.4 Metronidazole Market Restraints
14 Key Findings in The Global Metronidazole Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 123
USD 2900.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 168
USD 4900.00
(Single User License)
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 154
USD 5900.00
(Single User License)
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 123
USD 3950.00
(Single User License)
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published Date: 2025-01-16
Pages: 95
USD 2900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-17
Pages: 179
USD 5600.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-16
Pages: 170
USD 5900.00
(Single User License)
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 123
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 168
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 154
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 123
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Published: 2025-01-16
Pages: 95
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-17
Pages: 179
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-16
Pages: 170
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now